2019 CMCR Symposium

On Friday, October 18, 2019 the Center for Medicinal Cannabis Research (CMCR) held a one-day symposium celebrating the pioneers and exploring the progress, promise, and challenges of medicinal cannabis research. Click here to view an archive of the event broadcast.

Current CMCR studies

Current studies examine the effects of cannabis on pain and the potential benefits of CBD tinctures in the treatment of autistic children as well as public safety issues surrounding the use of cannabis and cannabinoids. The CMCR has recently funded 5 new research studies and as recruitment begins, the details of those studies can be found here.

CMCR announces $3M in new research grants to California investigators

The Center for Medicinal Cannabis Research (CMCR) at UC San Diego has been a leader in medical marijuana research since 2000. In the past CMCR has allocated funds to investigators in California to conduct some of the first proof of principle clinical trials of cannabis in neuropathic pain and multiple sclerosis. Learn more about the studies to be funded.

  • All
  • Announcements
  • Current Studies
  • Information
  • News
  • Presentations
  • Publications
  • Studies
  • Symposia
  • Default
  • Title
  • Date
  • Random
load more hold SHIFT key to load all load all

PI: Brook Henry, Ph.D. & Ron Ellis, M.D., Ph.D.

STUDY LOCATION: University of California, San Diego

PROJECT TITLE: Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

PROJECT TYPE: Clinical Study

STATUS: Active (Enrolling)

ABSTRACT:

HIV-associated neuropathic pain (HIV-NP) affects a significant proportion of people living with HIV (PLWH) and is one of the leading causes of disability in this population. Acute cannabis administration is reported to alleviate HIV-NP, but we have limited knowledge about the effects of cannabis constituents (THC and cannabidiol/CBD), the consequences of long-term cannabis use, and the impact of cannabis on endocannabinoid (EC) function in PLWH. Our objective is to address these three fundamental gaps in our knowledge by: 1) examining the acute effects of various CBD/THC products on HIV-NP, 2) utilizing a mHealth text messaging protocol (Individual Monitoring of Pain and Cannabis Taken or IMPACT) to monitor daily real-world cannabis use and changes in pain; 3) studying the relationship between cannabinoids, EC biomarkers, and chronic neuropathic pain.

This study will address these three fundamental gaps in our knowledge by: 1) examining the acute effects of various CBD/THC products on HIV-NP, 2) utilizing a mHealth text messaging protocol (Individual Monitoring of Pain and Cannabis Taken or IMPACT) to monitor daily real-world cannabis use and changes in pain; 3) studying the relationship between cannabinoids, EC biomarkers, and chronic neuropathic pain.